Browsing by Author "Sánchez González, Blanca"

Sort by: Order: Results:

  • Analysis of personality traits in patients with hodgkin lymphoma
    Roso-Bas, Fátima; Alonso-Llobregat, Maria Dolores; Bento, Leyre; Sánchez González, Blanca; Herraez, Ines; Garcia-Dilla, Pilar; Vallespir, Catalina; Rado, Francesca; Rodriguez, Raquel; Garcia Pallarols, Francesc; Aguirre, Irache; Bargay, Joan; Sampol, Antonia; Salar Silvestre, Antonio; Gutierrez, Antonio (MDPI, 2021)
    Hodgkin lymphoma (HL) is a highly-curable malignancy mostly affecting young people. As far as we know, there is no published study that has analyzed personality profiles in HL nor their potential role in lymphomagenesis, ...
  • Cell-Free DNA as a biomarker at diagnosis and follow-up in 256 B and T-Cell lymphomas
    Díez-Feijóo, Ramón; Andrade-Campos, Marcio; Gibert Fernandez, Joan, 1988-; Sánchez González, Blanca; Fernández-Ibarrondo, Lierni; Fernández Rodríguez, M. Concepción; García Gisbert, Nieves, 1994-; Camacho Díaz, Laura; Lafuente, Marta; Vázquez, Ivonne; Colomo Saperas, Luis Alberto; Salar Silvestre, Antonio; Bellosillo Paricio, Beatriz (MDPI, 2024)
    Background: Cell-free DNA (cfDNA) analysis has become a promising tool for the diagnosis, prognosis, and monitoring of lymphoma cases. Until now, research in this area has mainly focused on aggressive lymphomas, with scanty ...
  • Cell-free DNA for genomic analysis in primary mediastinal large B-cell lymphoma
    Rivas-Delgado, Alfredo; Nadeu, Ferran; Andrade-Campos, Marcio; López, Cristina; Enjuanes¸ Anna; Mozas, Pablo; Frigola, Gerard; Colomo Saperas, Luis Alberto; Sánchez González, Blanca; Villamor, Neus; Beà, Sílvia; Campo, Elias; Salar Silvestre, Antonio; Giné, Eva; López Guillermo, Armando; Bellosillo Paricio, Beatriz (MDPI, 2022)
    High-throughput sequencing of cell-free DNA (cfDNA) has emerged as a promising noninvasive approach in lymphomas, being particularly useful when a biopsy specimen is not available for molecular analysis, as it frequently ...
  • Evaluation of four prognostic indices in follicular lymphoma treated in first line with immunochemotherapy
    Rodríguez-Sevilla, Juan José; Fernández Rodríguez, M. Concepción; Bento, Leyre; Díez-Feijóo, Ramón; Felipe Pinzon, Sergio; Gibert Fernandez, Joan, 1988-; Fernández-Ibarrondo, Lierni; Lafuente, Marta; Ferrer Del Alamo, Ana; Sánchez González, Blanca; Gimeno Vázquez, Eva; Sainz, Juan; Ramos-Asensio, Rafael; García, Juan Fernando; Colomo Saperas, Luis Alberto; Bellosillo Paricio, Beatriz; Gutierrez, Antonio; Salar Silvestre, Antonio (American Society of Hematology, 2022)
    Several clinical risk models have been proposed to predict outcome in follicular lymphoma (FL). The development of Next Generation Sequencing (NGS) technologies has allowed the integration of somatic gene mutations in ...
  • Novel therapies to address unmet needs in ITP
    Mingot-Castellano, M. Eva; Bastida, José María; Caballero-Navarro, Gonzalo; Entrena Ureña, Laura; González-López, Tomás José; González Porras, José Ramón; Butta, Nora; Canaro, Mariana; Jiménez-Bárcenas, Reyes; Gómez Del Castillo Solano, María Del Carmen; Sánchez González, Blanca; Pascual-Izquierdo, Cristina; GEPTI (MDPI, 2022)
    Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current corticosteroid-based ITP therapies are able to improve platelet counts, up to ...
  • Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
    Newland, Adrian C.; Sánchez González, Blanca; Rejtő, László; Egyed, Miklos; Romanyuk, Nataliya; Godar, Marie; Verschueren, Katrien; Gandini, Domenica; Ulrichts, Peter; Beauchamp, Jon; Dreier, Torsten; Ward, E. Sally; Michel, Marc; Liebman, Howard A.; de Haard, Hans; Leupin, Nicolas; Kuter, David J. (Wiley-Blackwell, 2020)
    Primary immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder, characterized by a low platelet count (<100 × 109 /L) in the absence of other causes associated with thrombocytopenia. In most patients, ...
  • Psoriasiform eruption secondary to PI3K-delta inhibitor: expanding the spectrum of psoriasiform paradoxical reactions?
    Pesqué, David; Sánchez González, Blanca; Gallardo Hernández, Fernando; Segura Tigell, Sonia; Pujol Vallverdú, Ramon Maria (Society for Publication of Acta Dermato-Venereologica, 2021)
  • Recommendations for the clinical approach to immune thrombocytopenia: Spanish ITP working group (GEPTI)
    Mingot-Castellano, M. Eva; Sánchez González, Blanca; Spanish Immune Thrombocytopenia Group (GEPTI) (MDPI, 2023)
    Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity ...
  • Recommendations on the management of patients with immune thrombocytopenia (ITP) in the context of SARS-CoV-2 infection and vaccination: Consensus guidelines from a Spanish ITP expert group
    González-López, Tomás José; Bárez, Abelardo; Bernardo-Gutiérrez, Angel; Bernat, Silvia; Canaro, Mariana; Entrena Ureña, Laura; Fernández Fuertes, Luis Fernando; Guinea de Castro, José María; Jiménez-Bárcenas, Reyes; Pascual-Izquierdo, Cristina; Sánchez González, Blanca; Jarque, Isidro (Springer, 2023)
    Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease with highly variable presentation, characteristics, and clinical course. Thrombocytopenia is a common complication of many viral infections, including ...
  • Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular Llymphoma after first-line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial
    Peñalver, Francisco-Javier; Márquez, José-Antonio; Durán, Soledad; Giraldo, Pilar; Martin, Alejandro; Montalbán, Carlos; Sancho, Juan Manuel; Ramírez, María-José; Terol, María-José; Capote, Francisco-Javier; Gutiérrez, Antonio; Sánchez González, Blanca; López, Andrés; Salar Silvestre, Antonio; Rodríguez-Caravaca, Gil; Canales, M.; Caballero, María Dolores; GELTAMO Group (Wiley, 2019)
    Background: Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods: This phase II trial evaluated the efficacy ...
  • SEGHI study: defining the best surveillance strategy in Hodgkin lymphoma after first-line treatment
    Bastos Oreiro, Mariana; Sánchez González, Blanca; GELTAMO Group (MDPI, 2021)
    The optimal strategy for early surveillance after first complete response is unclear in Hodgkin lymphoma. Thus, we compared the various follow-up strategies in a multicenter study. All the included patients had a negative ...
  • Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity
    Fernández Rodríguez, M. Concepción; Rodríguez-Sevilla, Juan José; Fernández-Ibarrondo, Lierni; Sánchez González, Blanca; Gibert Fernandez, Joan, 1988-; Bento, Leyre; García, Juan Fernando; Sancho, Juan Manuel; Díez-Feijóo, Ramón; Camacho Díaz, Laura; García-Retortillo, Montserrat; Gimeno Vázquez, Eva; Colomo Saperas, Luis Alberto; Gutierrez, Antonio; Bellosillo Paricio, Beatriz; Salar Silvestre, Antonio (American Society of Hematology, 2022)
    Epidemiological studies have demonstrated the association between hepatitis B virus (HBV) infection and B-cell non-Hodgkin lymphoma (NHL), mainly for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). We ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking